Cordyceps Side Effects

Reported Cordyceps side effects

Cordyceps is generally well tolerated at typical supplemental doses, with one of the better safety profiles among fungal supplements. Most reported side effects are mild and transient. Common side effects (1-10%): Mild gastrointestinal upset — nausea, loose stools, abdominal discomfort, particularly when starting supplementation or at higher doses Dry mouth, especially at doses above 3g/day Mild restlessness or difficulty falling asleep if taken late in the day (likely from adenosine and caffeine-adjacent alerting effects, though Cordyceps contains no caffeine) Headache in a minority of users Uncommon side effects (<1%): Allergic reactions (skin rash, itching) — more common in individuals with other mushroom allergies Altered menstrual patterns in women — case reports of changes, typically mild Mild elevations in liver enzymes — rare, generally reversible on discontinuation Increased bruising or bleeding — likely related to mild antiplatelet effects of adenosine derivatives Rare but serious: Heavy metal toxicity — associated almost exclusively with wild O. sinensis from Tibet, which can be contaminated with arsenic and lead from the high-altitude soil, and sometimes adulterated with metal powder to increase weight and price. Multiple cases of lead poisoning have been reported in consumers of wild Tibetan Cordyceps. This risk is absent or minimal with cultivated C. militaris and Cs-4 from reputable manufacturers Autoimmune activation — theoretical concern given immunomodulatory effects; case reports of flares in autoimmune conditions are limited but suggest caution Bleeding complications — case reports of increased bleeding in patients on anticoagulation, presumably via antiplatelet effects of adenosine; clinical significance is modest but warrants monitoring Hypoglycemia — in diabetics on hypoglycemic medications, Cordyceps' modest glucose-lowering effects could contribute to low blood sugar Drug interactions: Anticoagulants (warfarin, DOACs) and antiplatelet agents (aspirin, clopidogrel) — theoretical additive bleeding risk; monitor for bruising and bleeding Immunosuppressants (ciclosporin, tacrolimus, mycophenolate, biologics) — Cordyceps immune-activating properties may theoretically counteract immunosuppression; avoid in transplant recipients and active autoimmune disease Diabetes medications (insulin, sulfonylureas, metformin) — additive glucose-lowering effect possible; monitor blood glucose Testosterone and other hormonal therapies — Cordyceps may modestly affect testosterone levels; clinical significance unclear CYP450 substrates — limited data on significant cytochrome P450 interactions with Cordyceps at typical supplemental doses Cardiovascular considerations: Mild blood pressure lowering possible (additive with antihypertensives, particularly ACE inhibitors and calcium channel blockers) Theoretical concerns about arrhythmias due to adenosine content are not borne out in clinical practice at oral supplemental doses (oral bioavailability of free adenosine is very low) Pregnancy and lactation: No established safety data; traditionally avoided in pregnancy in Chinese medicine Should be avoided during pregnancy and breastfeeding due to lack of safety data

When to continue, reduce, or stop Cordyceps

Cordyceps contraindications

Cordyceps is generally very safe but has specific populations who should avoid it or use only under medical supervision: Absolute contraindications: Organ transplant recipients on immunosuppression — Cordyceps' immune-activating properties (β-glucan Dectin-1 signaling, NK cell activation) may theoretically counteract immunosuppression and trigger rejection Active autoimmune disease in flare — lupus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease flares; immune activation may worsen disease Pregnancy and breastfeeding — no established safety data; traditionally avoided in Chinese medicine during pregnancy Known mushroom allergy — cross-reactivity is uncommon but possible Relative contraindications (caution with medical supervision): Anticoagulation therapy (warfarin, DOACs) at therapeutic INR — Cordyceps may have mild antiplatelet effects; monitor for bruising/bleeding, consider checking INR if using warfarin Diabetes on intensive glycemic control — Cordyceps may modestly lower blood sugar; monitor glucose and adjust medications as needed Hormone-sensitive cancers (prostate, breast) — limited data on effects on testosterone and estrogen; caution in cancer patients, especially without oncologist input Hypotension or antihypertensive therapy — mild additive blood pressure lowering possible Stable autoimmune disease in remission — use cautiously; consider alternative adaptogens like Rhodiola if immune concerns Sources to avoid: **Wild Tibetan O. sinensis from unverified sources — heavy metal contamination risk (arsenic, lead); adulteration with metal powders has been documented Mycelium-on-grain products without clear labeling — often provide minimal active compound Suspicious "Cordyceps" blends combining multiple fungi without standardization Drug interactions (summary): Anticoagulants and antiplatelet agents — additive bleeding risk Immunosuppressants (cyclosporine, tacrolimus, azathioprine, mycophenolate, biologics) — may counteract immunosuppression Diabetes medications (insulin, sulfonylureas, metformin) — additive hypoglycemic effect Antihypertensives — mild additive blood pressure lowering Testosterone or hormone replacement — unclear clinical significance Red flags during supplementation requiring discontinuation:** Unexplained bruising, nosebleeds, or prolonged bleeding from minor cuts Symptoms of low blood sugar in diabetics (tremor, sweating, confusion) Flare of autoimmune symptoms Allergic symptoms (rash, itching, swelling, difficulty breathing) Persistent GI symptoms or new onset liver-related symptoms (jaundice, dark urine) Symptoms of heavy metal toxicity (abdominal pain, cognitive changes, peripheral neuropathy — particularly if using wild O. sinensis) Pediatric use: Limited safety data in children Traditional use in children exists in Chinese medicine but clinical trial data are essentially absent Avoid in children under 18 without specialist guidance Geriatric use: Generally well tolerated in older adults Most positive clinical trials (Chen 2010) have been in this population Monitor for interactions with polypharmacy common in older adults

Why vendor quality drives Cordyceps side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Cordyceps side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .